Reversible peripheral neuropathy associated with sodium stibogluconate therapy for American cutaneous leishmaniasis.
Brummitt
C F
CF
Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Porter
J A
JA
Herwaldt
B L
BL
D000967:Antimony Sodium Gluconate / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*
D000981:Antiprotozoal Agents; D000967:Antimony Sodium Gluconate